Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EX
- Chemical substanceL01EX28Repotrectinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Netherlands
CBG-MEB · 2 registrations
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
At a glance
- ATC code
- L01EX28
- Registers
- 6
- Registrations
- 8
- With their own page
- 6
- Companies
- 4
All medicines with Repotrectinib
Human medicines from every register that match Repotrectinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Augtyro | United States | 160MG, 40MG | capsule | Marketed | Bristol |
| Augtyro | European Union | Authorised | Bristol-Myers Squibb Pharma EEIG | ||
| AUGTYRO 160 mg harde capsules | Netherlands | Capsule, hard | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| AUGTYRO 40 mg harde capsules | Netherlands | Capsule, hard | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| AUGTYRO Capsules 40 mg | Taiwan | 膠囊劑 | Authorised | 再鼎台灣醫藥有限公司 | |
| Augtyro | Croatia | Authorised | |||
| Augtyro | Canada | 40 MG | Capsule | Cancelled | Bristol-Myers Squibb Canada |
| Augtyro | Canada | 160 MG | Capsule | Cancelled | Bristol-Myers Squibb Canada |